CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home »

ONCOLOGY. Vol. 14 No. 9
Pages: 1  2  3  
Next
 

Cancer, Unproven Therapies, and Magic

By Simon Wein, MD1 | September 1, 2000
1Palliative Care Physician, Department of Palliative Care, Peter MacCallum Cancer Institute, Melbourne, Australia

ABSTRACT: Commonly used by cancer patients, unproven therapies are treatments that the practitioner claims can alter the disease process although there is no proof to support the claim. The reasons for the popularity of uproven therapies fall into two categories—practical considerations and fundamental mechanisms. Research has implicated the following practical factors: a pragmatic search for relief of symptoms, expression of a philosophical view, a need to reestablish a sense of control in life, and dissatisfaction with conventional medicine. Fundamental mechanisms include traditional magic, the heroic individual, and a delusional pattern of thinking. Underpinning and generating these factors is the fear of death. Particularly in patients with cancer, this is not only a fear of nonexistence, but of loneliness, the unknown, pain, loss of control, and emptiness. The popularity of unproven therapies poses a challenge to the medical system at large, and oncologists, psycho-oncologists, and palliative-care physicians, in particular. The essence of the challenge is to understand the reasons for the use of unproven therapies, to analyze our own behavior, and conclude what if anything our response should be. Unproven therapies (as with magic, a sense of heroism, and delusional thinking) fulfill the function of resolving the inexplicable and the psychologically painful—ie, relieving the anxiety associated with cancer. [ONCOLOGY 14(9):1345-1350, 2000]

Credulity, as a mental and moral phenomenon, manifests itself in widely different ways, according as it chances to be—the daughter of fancy or terror.

—James Russell Lowell, Witchcraft, 1871

Introduction

Fear of death is a primary human emotion. It is nowhere more evident than in patients with cancer. This encompasses not only the fear of nonexistence, but of loneliness, the unknown, pain, loss of control, and emptiness. These sound like vague concepts until one is challenged by a patient, or is oneself in such a predicament. Becker minces no words: “The idea of death, or the fear of it, haunts the human animal like nothing else; it is the mainspring of human activity—activity designed largely to avoid the fatality of death.”[1]

The word cancer generates such fears, like the words plague and tuberculosis once did. As Becker implies, we repress our awareness of death most of the time.[1] With the diagnosis of cancer, however, the fear of death resurfaces in many, if not, most patients. The human psyche responds with a variety of defense and coping mechanisms to resuppress and psychologically “avoid the fatality of death.”

A popular social movement sweeping the world today is a poorly categorized set of behaviors and beliefs that fall under the rubric of complementary, or alternative, medicine. I, however, shall employ the utilitarian title of unproven therapies. It is my contention that the use of unproven therapies is a mechanism to deal with the fear of death—in particular, where associated with cancer.

Is the burgeoning use of unproven therapies a problem? Are there broader societal implications in the retreat from objective, rational thought in favor of irrational unproven therapies? Why do patients choose unproven therapies against the evidence? How should the patient and the practitioner of unproven therapies be approached? Is there something that we in the medical community are doing wrong? What is the impact on the oncology community?

Historical Perspective

In seeking to understand this phenomenon, it is instructive to put the use of these therapies into historical context. There have always been nostrums and folk remedies to heal the sick. Happle suggests that “alternative medicine represents the most ancient form of medicine and will continue to exist [and] meet the need of many people seeking some metaphysical bonds and a simple explanation of complex or inexplicable matters.”[2]

Numerous authors note that changes in the form and format of folk medicine are inextricably linked to the ambient culture, social charter, and current scientific trend.[3,4] Balms, potions, and lotions prescribed by witch doctors, magicians, and shamans were de rigueur before the advent of science and have been reinvented by like-minded folk to fit contemporary theories.[5] Motivation, though, has remained unaltered.

Definition and Classification

There has been an attempt to bring order to a complex taxonomic problem by incorporating unproven therapies under the umbrella term “complementary-alternative medicine.” This is not helpful.

Promoters of this terminology draw a distinction between alternative and complementary. Complementary is defined as therapies used in addition to conventional treatment. The aim of complementary therapy is to help patients cope with having cancer rather than influence the cancer process itself. Alternative therapy, on the other hand, refers to treatments that are purported to have an impact on cancer physiology, and even effect a cure.

This distinction is ambiguous, cumbersome, and taxonomically bewildering, largely because of significant overlap between the treatments in each group. The classic example is that some unproven therapy practitioners use meditation or mental imagery with the aim of reversing the disease process (unproven, alternative), whereas others might claim the same treatment as an aid to relaxation (proven, complementary).

Another grey area is that of life-style practices that include systems of belief. For example, how should we categorize massage, music therapy, tai chi, yoga, or prayer? All these practices help maintain a “good” feeling through complex cognitive-behavioral mechanisms. To classify these life-style choices as complementary-alternative medicine seems to be inexpedient and taxonomically nihilistic.

In my view, the definition of unproven therapies in cancer should be based on two essential criteria: First, the practitioner claims that the treatment can alter the disease process. Second, this claim has not been verified by accredited government organizations or evaluated by a peer-reviewed medical journal.[6] Other possible features include an unwillingness to submit to randomized controlled clinical trials, an irrational theoretical basis, and the placebo effect as the sole pathogenic mechanism. Unproven therapies would also include disproven treatments, that is, treatments that have been subjected to peer-reviewed controlled studies and have been found to be ineffective.[2]

Some authors prefer not to use the phrase unproven therapies since there are treatments in conventional medicine that have not been confirmed by evidenced-based studies. Be that as it may, there is a willingness to investigate such treatments in the spirit of rational science and to discard them if inappropriate. Evidence-based medicine is littered with such corpses.[7] The American Cancer Society calls unproven therapies questionable methods and defines them as life-style practices, clinical tests, or therapeutic modalities that are promoted for the prevention, diagnosis, or treatment of cancer, and that are, on the basis of careful review by scientists and/or clinicians, deemed to have no real value.[8]

Motives and Explanations

In order to appropriately respond to the phenomenon of unproven therapies, it is important to understand the motives and rationale for their use. A number of important studies have been conducted in recent years exploring practical reasons. However, fewer articles have looked at the more fundamental motives driving patients to seek unproven and irrational treatment.

Practical Considerations

Several studies have tried to dissect the reasons that people use unproven therapies. Astin[9] surveyed the general population (not just cancer patients) and found that users were more likely (1) to hold a holistic philosophy of life, ie, a belief in the importance of the body-mind-spirit interrelationship in health; (2) to suffer from anxiety and chronic pain; and (3) to belong to a cultural group that identified with environmentalism, feminism, spirituality, and personal-growth psychology. However, he found that dissatisfaction with conventional medicine was not a factor.

Burstein’s study[10] of early-stage breast cancer patients identified a strong association between the use of unproven therapies and anxiety, depression, and physical symptoms. Downer’s group[11] studied unselected oncology patients and found dissatisfaction with conventional treatment to be the result of side effects, loss of hope, and greater anxiety. A German group[12] looking at oncology outpatients found that most patients used unproven therapies to “build up resistance,” in conjunction with a philosophical bent to greater religious belief and concern about ecology. Less than 5% of users did so because of lack of confidence in, or failure of, conventional medicine.

Risberg[13] studied 630 cancer patients and found that users of unproven therapies had received a less hopeful prognosis than nonusers. Most employed unproven therapies in order to increase strength, relieve symptoms, and fight the adverse effects of treatment, with less than 10% using them for cure alone. Oneschuk[14] surveyed 143 advanced cancer patients and found that the primary reasons for their use of unproven therapies were well-being (35%) and anticancer effect (50%). Danielson[15] and Cassileth[16] described the prevalent attitude as being “nothing to lose.” Cancer patients are desperate, and practitioners of unproven therapies promise natural, side-effect–free treatment with better survival results.

In summary, most researchers found that the practical reasons that patients use unproven therapies are that they seek hope, want to be treated as a “whole person,” need to express a philosophical view, are conducting a pragmatic search for relief of symptoms (both physical and psychological), and desire a sense of reestablishing control in their lives. To a lesser extent, dissatisfaction with conventional treatment was noted to be a factor.

Pages: 1  2  3  
Next
 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.

  • Oldest First
  • Newest First

by Patrice A. Mills | August 14, 2011 6:34 AM EDT

I believe that a more emotionally balanced and in control and hopeful person is going to have a better death ,or is possibley going to have a remission of their symptoms, and be given more time.(.We dont like to see patients ripped off when they are vulnerable and desperate).I agree that that different treatments sought will depend upon the personality of the patient..The patient is bound to hear of and seek other treatments,To hear of a young vet who has osteosarcoma with secondaries ,and chooses to manage himself with prolonged meditation ,changes in his diet etc and to go on to full remission is amazing.I dont believe in miracles, but contained within that there is good fortune, and science at work






 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
IMAGE IQ

Lower Back Pain in an Elderly Man With a History of Localized Prostate Cancer
James B. Yu, MD1 , May 17, 2013

A 70-year-old man with a history of localized prostate cancer treated with whole-pelvis radiation therapy with a boost to the prostate, in conjunction with androgen deprivation therapy 7 years prior, presented with lower back pain. A bone scan revealed an area of activity in the sacrum. What is the most likely diagnosis?

More Image IQs 

 
FROM PHYSICIANS PRACTICE
Primary Care Can't Thrive Without Nurse Practitioners
Courtney H. Lyder, ND,  May 17, 2013
With a projected shortfall of primary-care physicians, it's time for alternate solutions to patient care. Nurse practitioners are one logical remedy.
VWhat Physicians Can Learn from the Allscripts EHR Lawsuit
Marisa Torrieri,  May 16, 2013
Lawsuit prompts question: What should physicians do to ensure they end up with a great EHR instead of buyer’s remorse?
Eight Ways ICD-9 Will Still Matter to Medical Practices
Brenda Edwards, CPC,  May 15, 2013
What should your medical practice do with your ICD-9-CM book after October 1, 2014? Keep it.
Seven Ways Technology Can Speed Up Patient Collections
Cheyenne Brinson,  May 15, 2013
Failing to adopt widely available billing and collections technology can cost medical practices big. Here's how to do it right.
Four Reasons Private Medical Practice is Becoming Extinct
Carol Stryker,  May 15, 2013
It’s becoming increasingly difficult for private medical practices to thrive. Here’s what’s driving the trend toward consolidation.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Skin Lesions
  • Colorectal Lesions
  • “This Is My Last Day on Earth”
  • Slide Show: Squamous Cell Carcinoma of the Head and Neck
  • The ABCDEs of Moles and Melanomas
  • “This Is My Last Day on Earth”
  • Accelerated Partial-Breast Irradiation: The Current State of Our Knowledge
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Colorectal Lesions
  • New AUA Guidelines for Prostate Cancer Screening
  • 50 Shades of Pink—And Why It Helps to Know the Difference
  • Genomics Studies Identify Testicular Cancer Risk Variants
  • Lower Back Pain in an Elderly Man With a History of Localized Prostate Cancer
  • FDA Approves Erlotinib (Tarceva) as First-Line Lung Cancer Therapy for Certain Patients
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • “This Is My Last Day on Earth”
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
  • Patient Quality of Life Endpoints in Oncology Trials, Part II
  • Who's Coding Whom?
  • “How Do I Say This Nicely? Your Oncologist Wasn't Following Guidelines”
  • Study: Cholesterol Drugs Reduced Risk of Prostate Cancer Death
  • “This Is My Last Day on Earth”
  • ONS: Safe Handling of Chemotherapy
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
  • Conflicts of Interest in Medicine: What About Ties to Payers?
Click here to subscribe to our newsletter



CancerNetwork on Facebook

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy